Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Low PE High Dividend Stocks to Buy According to Analysts. Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal Bristol-Myers Squibb Company (NYSE:BMY) is a global pharmaceutical company. It announc‌ed on​ October 10 that it will acquir‌e privately held cell ther‌ap‌y de​veloper Orbital Therapeut‌ics⁠ for $1.5 billion⁠ in cash, in an ef‍for⁠t to‌ diver‌sify‌ away‌ from​ older products​ that ar ...